Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Get more Watchlists, Portfolios, Custom Views and Chart Templates with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Alkermes Plc (ALKS)

Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 4,072,259
  • Shares Outstanding, K 169,184
  • Annual Sales, $ 1,663 M
  • Annual Income, $ 355,760 K
  • 60-Month Beta 0.56
  • Price/Sales 2.43
  • Price/Cash Flow 10.47
  • Price/Book 3.30
Trade ALKS with:

Options Overview Details

View History
  • Implied Volatility 40.42% ( -0.65%)
  • Historical Volatility 26.99%
  • IV Percentile 77%
  • IV Rank 57.57%
  • IV High 55.09% on 04/16/24
  • IV Low 20.52% on 11/28/23
  • Put/Call Vol Ratio 0.04
  • Today's Volume 57
  • Volume Avg (30-Day) 1,443
  • Put/Call OI Ratio 0.38
  • Today's Open Interest 5,461
  • Open Int (30-Day) 19,494

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.49
  • Number of Estimates 4
  • High Estimate 0.53
  • Low Estimate 0.38
  • Prior Year -0.10
  • Growth Rate Est. (year over year) +590.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
23.48 +3.32%
on 04/19/24
27.57 -11.99%
on 03/25/24
-3.03 (-11.10%)
since 03/22/24
3-Month
23.48 +3.32%
on 04/19/24
32.88 -26.22%
on 02/16/24
-4.28 (-15.00%)
since 01/23/24
52-Week
22.01 +10.22%
on 10/25/23
33.71 -28.03%
on 06/26/23
-5.12 (-17.43%)
since 04/21/23

Most Recent Stories

More News
Stocks Rebound as Bond Yields Fall Ahead of Wednesday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.39%. Stock indexes...

$SPX : 5,070.55 (+1.20%)
SPY : 505.65 (+1.19%)
$DOWI : 38,503.69 (+0.69%)
DIA : 385.02 (+0.69%)
$IUXX : 17,471.47 (+1.51%)
QQQ : 425.07 (+1.49%)
ZNM24 : 107-300 (-0.13%)
MRNA : 107.89 (+3.28%)
CSCO : 48.32 (+0.37%)
ON : 61.68 (+1.70%)
ADI : 189.93 (+1.94%)
GFS : 46.35 (-0.04%)
Stocks Retreat on Risk Aversion Ahead of Wednesday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) this morning is down -0.76%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.78%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.67%. Stock indexes this...

$SPX : 5,070.55 (+1.20%)
SPY : 505.65 (+1.19%)
$DOWI : 38,503.69 (+0.69%)
DIA : 385.02 (+0.69%)
$IUXX : 17,471.47 (+1.51%)
QQQ : 425.07 (+1.49%)
ZNM24 : 107-300 (-0.13%)
NVDA : 824.23 (+3.65%)
RCL : 136.67 (+3.55%)
CCL : 14.79 (+3.57%)
NCLH : 19.54 (+5.39%)
VZ : 39.70 (+2.85%)
Stocks Mixed Before Wednesday’s US CPI Report

The S&P 500 Index ($SPX ) (SPY ) this morning is up +0.07%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.16%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.31%. Stock indexes this morning...

$SPX : 5,070.55 (+1.20%)
SPY : 505.65 (+1.19%)
$DOWI : 38,503.69 (+0.69%)
DIA : 385.02 (+0.69%)
$IUXX : 17,471.47 (+1.51%)
QQQ : 425.07 (+1.49%)
ZNM24 : 107-300 (-0.13%)
FCX : 47.99 (-1.96%)
NDAQ : 61.09 (-0.18%)
ILMN : 124.46 (+3.50%)
ON : 61.68 (+1.70%)
GFS : 46.35 (-0.04%)
Alkermes: Q4 Earnings Snapshot

Alkermes: Q4 Earnings Snapshot

ALKS : 24.26 (+0.79%)
3 Top Growth Stocks to Buy for December 2023

Here are three of the best growth stocks to buy right now, based on solid earnings performance, encouraging 2024 forecasts, and enthusiastic ratings from Wall Street analysts.

ALKS : 24.26 (+0.79%)
FROG : 39.17 (+3.79%)
FOUR : 61.67 (+1.07%)
Why Alkermes Stock Is Sinking Today

The biotech company's Q3 revenue and earnings looked great, but the results weren't enough to wow investors.

ALKS : 24.26 (+0.79%)
Alkermes: Q3 Earnings Snapshot

Alkermes: Q3 Earnings Snapshot

ALKS : 24.26 (+0.79%)
Alkermes to Report Third Quarter Financial Results on October 25, 2023

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) will host a conference call and webcast presentation at 8:00 a.m. ET (1:00 p.m. BST) on Wednesday, Oct. 25, 2023 to...

ALKS : 24.26 (+0.79%)
Mural Oncology to Host Investor Webcast on October 17

/PRNewswire/ -- Mural Oncology plc, the publicly-traded oncology company that Alkermes plc (Nasdaq: ALKS) plans to establish in the fourth quarter of 2023...

ALKS : 24.26 (+0.79%)
Alkermes to Present First Clinical Data for Orexin 2 Receptor Agonist ALKS 2680 at World Sleep Congress

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced plans to present new data related to ALKS 2680, the company's novel, investigational orexin 2...

ALKS : 24.26 (+0.79%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Alkermes plc, formed by the merger of Waltham, MA-based Alkermes, Inc. and Elan Drug Technologies (EDT), is a fully integrated global biopharmaceutical company that utilizes proprietary technologies to research, develop and commercialize, both with partners and on its own pharmaceutical products in major...

See More

Key Turning Points

3rd Resistance Point 25.14
2nd Resistance Point 24.89
1st Resistance Point 24.57
Last Price 24.26
1st Support Level 24.00
2nd Support Level 23.75
3rd Support Level 23.43

See More

52-Week High 33.71
Fibonacci 61.8% 29.24
Fibonacci 50% 27.86
Fibonacci 38.2% 26.48
Last Price 24.26
52-Week Low 22.01

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar